☆ 4.6 Article

Cortical inhibition function is associated with baseline suicidal symptoms and post-ketamine suicidal symptom reduction among patients with treatment-resistant depression and strong suicidal ideation

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan

Wei-Lieh Huang et al.

Summary: A study conducted in Taiwan using population-based data found that approximately one-third of patients with pharmaceutically treated depression (PTD) developed treatment-resistant depression (TRD) after receiving adequate pharmacological treatment. The study also showed that TRD patients utilized more medical resources compared to non-TRD PTD patients.

JOURNAL OF AFFECTIVE DISORDERS (2022)

添加到收藏夹

Article Clinical Neurology

A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine

Bartholt Bloomfield-Clagett et al.

Summary: This study investigates the differential placebo response for suicidal ideation compared to other depressive symptoms in clinical trials of IV ketamine. The findings suggest that placebo response for suicidal ideation may be different from other symptoms, which may explain the less prominent effect of IV ketamine on suicidal ideation compared to overall depression.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Psychiatry

Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Alize J. Ferrari et al.

Summary: The Global Burden of Diseases Study in 2019 showed that mental disorders remained among the top ten leading causes of burden worldwide, with no reduction in burden since 1990. The majority of the burden in disability-adjusted life-years (DALYs) came from years lived with disability (YLDs).

LANCET PSYCHIATRY (2022)

添加到收藏夹

Article Medicine, General & Internal

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

Damian F. Santomauro et al.

Summary: This study aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. The findings showed that the pandemic led to increased prevalence of major depressive disorder and anxiety disorders, with females and younger age groups being more affected. The pandemic has created an increased urgency to strengthen mental health systems in most countries and mitigation strategies are needed to address the burden of these mental disorders.

LANCET (2021)

添加到收藏夹

Article Neurosciences

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy

Jennifer I. Lissemore et al.

Summary: The study found that after 12 weeks of venlafaxine treatment, cortical inhibition, facilitation, and plasticity did not significantly change in patients with late-life depression. Improvement in depressive symptoms during treatment was not associated with changes in cortical physiology.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2021)

添加到收藏夹

Article Psychiatry

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression

Erik D. Fagerholm et al.

Summary: The study examined changes in neural dynamics in the primary somatosensory cortex of unmedicated TRD patients and healthy controls following ketamine treatment. The results showed that ketamine improved depressive symptoms by increasing excitatory and inhibitory coupling in the brain, as evidenced by shifts in Poincare diagram coordinates. The drug-specific nature of the results was verified by the lack of a similar effect with placebo.

TRANSLATIONAL PSYCHIATRY (2021)

添加到收藏夹

Article Psychiatry

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study

Johan Reutfors et al.

Summary: The study revealed that risk factors for suicide and suicide attempts among patients with TRD include history of suicide attempts, education level, substance abuse, and other clinical factors.

ARCHIVES OF SUICIDE RESEARCH (2021)

添加到收藏夹

Article Psychology, Clinical

Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition

Jia-Shyun Jeng et al.

PSYCHOLOGICAL MEDICINE (2020)

添加到收藏夹

Review Psychology, Clinical

Defining treatment-resistant depression

Bradley N. Gaynes et al.

DEPRESSION AND ANXIETY (2020)

添加到收藏夹

Article Clinical Neurology

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder

Deniz Doruk Camsari et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Psychiatry

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Carla M. Canuso et al.

AMERICAN JOURNAL OF PSYCHIATRY (2018)

添加到收藏夹

Article Clinical Neurology

A reappraisal of the mechanisms of action of ketamine to treat complex regional pain syndrome in the light of cortical excitability changes

Marc Sorel et al.

CLINICAL NEUROPHYSIOLOGY (2018)

添加到收藏夹

Editorial Material Medicine, General & Internal

Randomization in Clinical Trials Permuted Blocks and Stratification

Kristine Broglio

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

添加到收藏夹

Article Neurosciences

Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents

Charles P. Lewis et al.

NEUROPSYCHOPHARMACOLOGY (2018)

添加到收藏夹

Article Psychology, Clinical

Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action

Chittaranjan Andrade

JOURNAL OF CLINICAL PSYCHIATRY (2017)

添加到收藏夹

Article Neurosciences

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression

Tung-Ping Su et al.

NEUROPSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Article Clinical Neurology

Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation

Albino J. Oliveira-Maia et al.

BRAIN STIMULATION (2017)

添加到收藏夹

Article Clinical Neurology

Cortical inhibitory and excitatory function in drug-naive generalized anxiety disorder

Cheng-Ta Li et al.

BRAIN STIMULATION (2017)

添加到收藏夹

Article Clinical Neurology

Cortical inhibitory and excitatory correlates of depression severity in children and adolescents

Charles P. Lewis et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

添加到收藏夹

Article Psychiatry

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant

Elizabeth D. Ballard et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2015)

添加到收藏夹

Article Clinical Neurology

Evidence for Pretreatment LICI Deficits Among Depressed Children and Adolescents With Nonresponse to Fluoxetine

Paul E. Croarkin et al.

BRAIN STIMULATION (2014)

添加到收藏夹

Article Psychiatry

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

James W. Murrough et al.

AMERICAN JOURNAL OF PSYCHIATRY (2013)

添加到收藏夹

Article Clinical Neurology

A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders

Natasha Radhu et al.

CLINICAL NEUROPHYSIOLOGY (2013)

添加到收藏夹

Article Psychiatry

Treatment-Resistant Depression and Risk of Suicide

Paul N. Pfeiffer et al.

SUICIDE AND LIFE-THREATENING BEHAVIOR (2013)

添加到收藏夹

Article Psychiatry

The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

Kelly Posner et al.

AMERICAN JOURNAL OF PSYCHIATRY (2011)

添加到收藏夹

Review Behavioral Sciences

Evidence for GABAergic inhibitory deficits in major depressive disorder

Paul E. Croarkin et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)

添加到收藏夹

Article Neurosciences

Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder

Andrea J. Levinson et al.

BIOLOGICAL PSYCHIATRY (2010)

添加到收藏夹

Article Nursing

Sequenced Treatment Alternatives to Relieve Depression (star*d)

Robert H. Howland

JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2009)

添加到收藏夹

Article Neurosciences

Evidence for impaired cortical inhibition in patients with unipolar major depression

M Bajbouj et al.

BIOLOGICAL PSYCHIATRY (2006)

添加到收藏夹

Article Clinical Neurology

Motor cortical excitability and clinical response to rTMS in depression

PB Fitzgerald et al.

JOURNAL OF AFFECTIVE DISORDERS (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.